Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

No GRASE For Ibuprofen, No Future In OTC Internal Analgesic Monograph

May 14 2018

• By Malcolm Spicer

FDASignBldg21Entrance_1200x675

Related Content

FDA Expands Acetaminophen, NSAID Labeling Beyond Tentative Final Rule

May 04 2009

OTC NSAIDs Need Additional Label Warnings – FDA Advisory Panel

Feb 19 2014

OTC Naproxen Labeling: US FDA Advisory Panel Finds Imprecise Direction In PRECISION

Apr 27 2018

Related Companies

Johnson & Johnson

Pfizer Inc.

Additional Topics

United States Drug Approval Standards Safety OTC Drugs Cosmetics Inflammation Consumer Gastrointestinal Cardiovascular

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window